EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 48 filers reported holding EPIZYME INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $8,079,000 | +18.9% | 428,145 | +70.8% | 0.70% | +7.7% |
| Q3 2014 | $6,796,000 | -13.2% | 250,678 | -0.4% | 0.65% | -9.6% |
| Q2 2014 | $7,834,000 | +41.7% | 251,748 | +3.7% | 0.72% | +36.1% |
| Q1 2014 | $5,529,000 | +67.6% | 242,838 | +126.1% | 0.53% | +168.5% |
| Q4 2013 | $3,298,000 | +70.6% | 107,390 | +56.3% | 0.20% | -39.8% |
| Q2 2013 | $1,933,000 | – | 68,719 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |